nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—SLCO2B1—Tolbutamide—type 2 diabetes mellitus	0.0871	0.115	CbGbCtD
Fexofenadine—SLCO1B3—Pioglitazone—type 2 diabetes mellitus	0.0868	0.115	CbGbCtD
Fexofenadine—SLCO1B3—Valsartan—type 2 diabetes mellitus	0.0708	0.0936	CbGbCtD
Fexofenadine—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.0559	0.0739	CbGbCtD
Fexofenadine—SLCO1B1—Pioglitazone—type 2 diabetes mellitus	0.0505	0.0669	CbGbCtD
Fexofenadine—SLCO2B1—Glyburide—type 2 diabetes mellitus	0.05	0.0662	CbGbCtD
Fexofenadine—SLCO1A2—Tolbutamide—type 2 diabetes mellitus	0.0478	0.0632	CbGbCtD
Fexofenadine—SLCO1B1—Rosiglitazone—type 2 diabetes mellitus	0.0467	0.0617	CbGbCtD
Fexofenadine—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.0412	0.0545	CbGbCtD
Fexofenadine—SLCO1B3—Losartan—type 2 diabetes mellitus	0.0406	0.0537	CbGbCtD
Fexofenadine—SLCO1A2—Glyburide—type 2 diabetes mellitus	0.0274	0.0363	CbGbCtD
Fexofenadine—SLCO1B1—Losartan—type 2 diabetes mellitus	0.0237	0.0313	CbGbCtD
Fexofenadine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0225	0.0297	CbGbCtD
Fexofenadine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.02	0.0265	CbGbCtD
Fexofenadine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0145	0.0191	CbGbCtD
Fexofenadine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0136	0.018	CbGbCtD
Fexofenadine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0126	0.0167	CbGbCtD
Fexofenadine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0103	0.0137	CbGbCtD
Fexofenadine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00995	0.0132	CbGbCtD
Fexofenadine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00991	0.0131	CbGbCtD
Fexofenadine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00741	0.0098	CbGbCtD
Fexofenadine—ABCB1—Losartan—type 2 diabetes mellitus	0.00678	0.00897	CbGbCtD
Fexofenadine—Pimozide—CALM1—type 2 diabetes mellitus	0.000591	0.201	CrCbGaD
Fexofenadine—Loperamide—CALM1—type 2 diabetes mellitus	0.000493	0.168	CrCbGaD
Fexofenadine—Lomitapide—CYP3A4—type 2 diabetes mellitus	0.000431	0.147	CrCbGaD
Fexofenadine—Fluspirilene—ADRA2A—type 2 diabetes mellitus	0.000358	0.122	CrCbGaD
Fexofenadine—Palpitations—Valsartan—type 2 diabetes mellitus	0.000237	0.00137	CcSEcCtD
Fexofenadine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000237	0.00136	CcSEcCtD
Fexofenadine—Infection—Gliclazide—type 2 diabetes mellitus	0.000237	0.00136	CcSEcCtD
Fexofenadine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000236	0.00136	CcSEcCtD
Fexofenadine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000236	0.00136	CcSEcCtD
Fexofenadine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000236	0.00136	CcSEcCtD
Fexofenadine—Palpitations—Orlistat—type 2 diabetes mellitus	0.000234	0.00135	CcSEcCtD
Fexofenadine—Cough—Valsartan—type 2 diabetes mellitus	0.000234	0.00135	CcSEcCtD
Fexofenadine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000234	0.00135	CcSEcCtD
Fexofenadine—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000233	0.00135	CcSEcCtD
Fexofenadine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000232	0.00134	CcSEcCtD
Fexofenadine—Cough—Orlistat—type 2 diabetes mellitus	0.000231	0.00133	CcSEcCtD
Fexofenadine—Flushing—Losartan—type 2 diabetes mellitus	0.000231	0.00133	CcSEcCtD
Fexofenadine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000231	0.00133	CcSEcCtD
Fexofenadine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00023	0.00133	CcSEcCtD
Fexofenadine—Vision blurred—Metformin—type 2 diabetes mellitus	0.00023	0.00133	CcSEcCtD
Fexofenadine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00023	0.00133	CcSEcCtD
Fexofenadine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000229	0.00132	CcSEcCtD
Fexofenadine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000229	0.00132	CcSEcCtD
Fexofenadine—Myalgia—Valsartan—type 2 diabetes mellitus	0.000228	0.00132	CcSEcCtD
Fexofenadine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000228	0.00131	CcSEcCtD
Fexofenadine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000227	0.00131	CcSEcCtD
Fexofenadine—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000227	0.00131	CcSEcCtD
Fexofenadine—Tension—Irbesartan—type 2 diabetes mellitus	0.000226	0.0013	CcSEcCtD
Fexofenadine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000226	0.0013	CcSEcCtD
Fexofenadine—Myalgia—Orlistat—type 2 diabetes mellitus	0.000225	0.0013	CcSEcCtD
Fexofenadine—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000224	0.00129	CcSEcCtD
Fexofenadine—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000224	0.00129	CcSEcCtD
Fexofenadine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000223	0.00129	CcSEcCtD
Fexofenadine—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000223	0.00129	CcSEcCtD
Fexofenadine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000221	0.00127	CcSEcCtD
Fexofenadine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00022	0.00127	CcSEcCtD
Fexofenadine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000219	0.00126	CcSEcCtD
Fexofenadine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000219	0.00126	CcSEcCtD
Fexofenadine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000219	0.00126	CcSEcCtD
Fexofenadine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000218	0.00126	CcSEcCtD
Fexofenadine—Infection—Valsartan—type 2 diabetes mellitus	0.000217	0.00125	CcSEcCtD
Fexofenadine—Rash—Glipizide—type 2 diabetes mellitus	0.000217	0.00125	CcSEcCtD
Fexofenadine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000217	0.00125	CcSEcCtD
Fexofenadine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000217	0.00125	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000217	0.00125	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000217	0.00125	CcSEcCtD
Fexofenadine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000216	0.00125	CcSEcCtD
Fexofenadine—Headache—Glipizide—type 2 diabetes mellitus	0.000216	0.00124	CcSEcCtD
Fexofenadine—Palpitations—Metformin—type 2 diabetes mellitus	0.000216	0.00124	CcSEcCtD
Fexofenadine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000215	0.00124	CcSEcCtD
Fexofenadine—Infection—Orlistat—type 2 diabetes mellitus	0.000215	0.00124	CcSEcCtD
Fexofenadine—Flatulence—Losartan—type 2 diabetes mellitus	0.000214	0.00123	CcSEcCtD
Fexofenadine—Tension—Losartan—type 2 diabetes mellitus	0.000213	0.00123	CcSEcCtD
Fexofenadine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000213	0.00123	CcSEcCtD
Fexofenadine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000212	0.00122	CcSEcCtD
Fexofenadine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000212	0.00122	CcSEcCtD
Fexofenadine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000212	0.00122	CcSEcCtD
Fexofenadine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000212	0.00122	CcSEcCtD
Fexofenadine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000211	0.00121	CcSEcCtD
Fexofenadine—Nervousness—Losartan—type 2 diabetes mellitus	0.000211	0.00121	CcSEcCtD
Fexofenadine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00021	0.00121	CcSEcCtD
Fexofenadine—Back pain—Losartan—type 2 diabetes mellitus	0.00021	0.00121	CcSEcCtD
Fexofenadine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00021	0.00121	CcSEcCtD
Fexofenadine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.00021	0.00121	CcSEcCtD
Fexofenadine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000208	0.0012	CcSEcCtD
Fexofenadine—Myalgia—Metformin—type 2 diabetes mellitus	0.000208	0.0012	CcSEcCtD
Fexofenadine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000207	0.00119	CcSEcCtD
Fexofenadine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000205	0.00118	CcSEcCtD
Fexofenadine—Nausea—Glipizide—type 2 diabetes mellitus	0.000205	0.00118	CcSEcCtD
Fexofenadine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000204	0.00118	CcSEcCtD
Fexofenadine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000204	0.00118	CcSEcCtD
Fexofenadine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000204	0.00117	CcSEcCtD
Fexofenadine—Pain—Gliclazide—type 2 diabetes mellitus	0.000204	0.00117	CcSEcCtD
Fexofenadine—Rash—Glimepiride—type 2 diabetes mellitus	0.000203	0.00117	CcSEcCtD
Fexofenadine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000203	0.00117	CcSEcCtD
Fexofenadine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000202	0.00116	CcSEcCtD
Fexofenadine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000202	0.00116	CcSEcCtD
Fexofenadine—Headache—Glimepiride—type 2 diabetes mellitus	0.000201	0.00116	CcSEcCtD
Fexofenadine—Cough—Irbesartan—type 2 diabetes mellitus	0.000201	0.00116	CcSEcCtD
Fexofenadine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000201	0.00116	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000199	0.00115	CcSEcCtD
Fexofenadine—Agitation—Losartan—type 2 diabetes mellitus	0.000199	0.00115	CcSEcCtD
Fexofenadine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000198	0.00114	CcSEcCtD
Fexofenadine—Flushing—Ramipril—type 2 diabetes mellitus	0.000198	0.00114	CcSEcCtD
Fexofenadine—Angioedema—Losartan—type 2 diabetes mellitus	0.000198	0.00114	CcSEcCtD
Fexofenadine—Infection—Metformin—type 2 diabetes mellitus	0.000198	0.00114	CcSEcCtD
Fexofenadine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000198	0.00114	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000197	0.00114	CcSEcCtD
Fexofenadine—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000196	0.00113	CcSEcCtD
Fexofenadine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000196	0.00113	CcSEcCtD
Fexofenadine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000195	0.00113	CcSEcCtD
Fexofenadine—Pimozide—CYP2E1—type 2 diabetes mellitus	0.000195	0.0665	CrCbGaD
Fexofenadine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000195	0.00112	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000195	0.00112	CcSEcCtD
Fexofenadine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000194	0.00112	CcSEcCtD
Fexofenadine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000193	0.00111	CcSEcCtD
Fexofenadine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000192	0.00111	CcSEcCtD
Fexofenadine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000192	0.00111	CcSEcCtD
Fexofenadine—Palpitations—Losartan—type 2 diabetes mellitus	0.000192	0.0011	CcSEcCtD
Fexofenadine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000191	0.0011	CcSEcCtD
Fexofenadine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00019	0.0011	CcSEcCtD
Fexofenadine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00019	0.0011	CcSEcCtD
Fexofenadine—Asthenia—Glyburide—type 2 diabetes mellitus	0.00019	0.0011	CcSEcCtD
Fexofenadine—Cough—Losartan—type 2 diabetes mellitus	0.000189	0.00109	CcSEcCtD
Fexofenadine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000189	0.00109	CcSEcCtD
Fexofenadine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000189	0.00109	CcSEcCtD
Fexofenadine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000188	0.00108	CcSEcCtD
Fexofenadine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000188	0.00108	CcSEcCtD
Fexofenadine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000188	0.00108	CcSEcCtD
Fexofenadine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000188	0.00108	CcSEcCtD
Fexofenadine—Infection—Irbesartan—type 2 diabetes mellitus	0.000187	0.00108	CcSEcCtD
Fexofenadine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000186	0.00107	CcSEcCtD
Fexofenadine—Pimozide—CYP1A2—type 2 diabetes mellitus	0.000186	0.0633	CrCbGaD
Fexofenadine—Pain—Orlistat—type 2 diabetes mellitus	0.000185	0.00107	CcSEcCtD
Fexofenadine—Myalgia—Losartan—type 2 diabetes mellitus	0.000185	0.00106	CcSEcCtD
Fexofenadine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000184	0.00106	CcSEcCtD
Fexofenadine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000183	0.00106	CcSEcCtD
Fexofenadine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000183	0.00105	CcSEcCtD
Fexofenadine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000183	0.00105	CcSEcCtD
Fexofenadine—Tension—Ramipril—type 2 diabetes mellitus	0.000182	0.00105	CcSEcCtD
Fexofenadine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000182	0.00105	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000181	0.00105	CcSEcCtD
Fexofenadine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000181	0.00105	CcSEcCtD
Fexofenadine—Nervousness—Ramipril—type 2 diabetes mellitus	0.000181	0.00104	CcSEcCtD
Fexofenadine—Dry mouth—Losartan—type 2 diabetes mellitus	0.00018	0.00104	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000179	0.00103	CcSEcCtD
Fexofenadine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000178	0.00102	CcSEcCtD
Fexofenadine—Somnolence—Metformin—type 2 diabetes mellitus	0.000177	0.00102	CcSEcCtD
Fexofenadine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000177	0.00102	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000177	0.00102	CcSEcCtD
Fexofenadine—Infection—Losartan—type 2 diabetes mellitus	0.000176	0.00101	CcSEcCtD
Fexofenadine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000175	0.00101	CcSEcCtD
Fexofenadine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000175	0.00101	CcSEcCtD
Fexofenadine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000174	0.001	CcSEcCtD
Fexofenadine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000173	0.000997	CcSEcCtD
Fexofenadine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000173	0.000995	CcSEcCtD
Fexofenadine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000172	0.000993	CcSEcCtD
Fexofenadine—Fatigue—Metformin—type 2 diabetes mellitus	0.000172	0.00099	CcSEcCtD
Fexofenadine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000172	0.00099	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000171	0.000987	CcSEcCtD
Fexofenadine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000171	0.000985	CcSEcCtD
Fexofenadine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000171	0.000985	CcSEcCtD
Fexofenadine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000171	0.000985	CcSEcCtD
Fexofenadine—Agitation—Ramipril—type 2 diabetes mellitus	0.000171	0.000985	CcSEcCtD
Fexofenadine—Angioedema—Ramipril—type 2 diabetes mellitus	0.00017	0.000979	CcSEcCtD
Fexofenadine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000169	0.000972	CcSEcCtD
Fexofenadine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000168	0.000971	CcSEcCtD
Fexofenadine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000168	0.000966	CcSEcCtD
Fexofenadine—Rash—Glyburide—type 2 diabetes mellitus	0.000167	0.000964	CcSEcCtD
Fexofenadine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000167	0.000963	CcSEcCtD
Fexofenadine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000167	0.000963	CcSEcCtD
Fexofenadine—Headache—Glyburide—type 2 diabetes mellitus	0.000166	0.000957	CcSEcCtD
Fexofenadine—Darifenacin—CYP3A4—type 2 diabetes mellitus	0.000166	0.0565	CrCbGaD
Fexofenadine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000165	0.000954	CcSEcCtD
Fexofenadine—Palpitations—Ramipril—type 2 diabetes mellitus	0.000164	0.000947	CcSEcCtD
Fexofenadine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000163	0.000939	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000163	0.000939	CcSEcCtD
Fexofenadine—Cough—Ramipril—type 2 diabetes mellitus	0.000162	0.000935	CcSEcCtD
Fexofenadine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000162	0.000934	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000161	0.000929	CcSEcCtD
Fexofenadine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000161	0.000929	CcSEcCtD
Fexofenadine—Pain—Irbesartan—type 2 diabetes mellitus	0.000161	0.000927	CcSEcCtD
Fexofenadine—Insomnia—Losartan—type 2 diabetes mellitus	0.00016	0.000922	CcSEcCtD
Fexofenadine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000159	0.000918	CcSEcCtD
Fexofenadine—Urticaria—Metformin—type 2 diabetes mellitus	0.000158	0.000912	CcSEcCtD
Fexofenadine—Myalgia—Ramipril—type 2 diabetes mellitus	0.000158	0.000912	CcSEcCtD
Fexofenadine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000158	0.000909	CcSEcCtD
Fexofenadine—Nausea—Glyburide—type 2 diabetes mellitus	0.000158	0.000908	CcSEcCtD
Fexofenadine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000157	0.000908	CcSEcCtD
Fexofenadine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000157	0.000907	CcSEcCtD
Fexofenadine—Somnolence—Losartan—type 2 diabetes mellitus	0.000157	0.000907	CcSEcCtD
Fexofenadine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000157	0.000905	CcSEcCtD
Fexofenadine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000156	0.000898	CcSEcCtD
Fexofenadine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000155	0.000894	CcSEcCtD
Fexofenadine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000155	0.000892	CcSEcCtD
Fexofenadine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000155	0.000892	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000154	0.000886	CcSEcCtD
Fexofenadine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000153	0.000881	CcSEcCtD
Fexofenadine—Fatigue—Losartan—type 2 diabetes mellitus	0.000153	0.000879	CcSEcCtD
Fexofenadine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000152	0.000874	CcSEcCtD
Fexofenadine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000151	0.000873	CcSEcCtD
Fexofenadine—Pain—Losartan—type 2 diabetes mellitus	0.000151	0.000872	CcSEcCtD
Fexofenadine—Rash—Gliclazide—type 2 diabetes mellitus	0.00015	0.000865	CcSEcCtD
Fexofenadine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00015	0.000864	CcSEcCtD
Fexofenadine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00015	0.000863	CcSEcCtD
Fexofenadine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000149	0.000861	CcSEcCtD
Fexofenadine—Headache—Gliclazide—type 2 diabetes mellitus	0.000149	0.00086	CcSEcCtD
Fexofenadine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000149	0.000857	CcSEcCtD
Fexofenadine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000149	0.000857	CcSEcCtD
Fexofenadine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000148	0.000853	CcSEcCtD
Fexofenadine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000148	0.000852	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000145	0.000834	CcSEcCtD
Fexofenadine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000145	0.000834	CcSEcCtD
Fexofenadine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000143	0.000824	CcSEcCtD
Fexofenadine—Asthenia—Metformin—type 2 diabetes mellitus	0.000143	0.000824	CcSEcCtD
Fexofenadine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000141	0.000815	CcSEcCtD
Fexofenadine—Pruritus—Metformin—type 2 diabetes mellitus	0.000141	0.000812	CcSEcCtD
Fexofenadine—Urticaria—Losartan—type 2 diabetes mellitus	0.000141	0.00081	CcSEcCtD
Fexofenadine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00014	0.000806	CcSEcCtD
Fexofenadine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00014	0.000806	CcSEcCtD
Fexofenadine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000139	0.000802	CcSEcCtD
Fexofenadine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000139	0.000798	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000138	0.000797	CcSEcCtD
Fexofenadine—Rash—Valsartan—type 2 diabetes mellitus	0.000138	0.000795	CcSEcCtD
Fexofenadine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000138	0.000794	CcSEcCtD
Fexofenadine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000137	0.000792	CcSEcCtD
Fexofenadine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000137	0.000791	CcSEcCtD
Fexofenadine—Headache—Valsartan—type 2 diabetes mellitus	0.000137	0.00079	CcSEcCtD
Fexofenadine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000136	0.000786	CcSEcCtD
Fexofenadine—Rash—Orlistat—type 2 diabetes mellitus	0.000136	0.000786	CcSEcCtD
Fexofenadine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000136	0.000785	CcSEcCtD
Fexofenadine—Headache—Orlistat—type 2 diabetes mellitus	0.000135	0.00078	CcSEcCtD
Fexofenadine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000135	0.00078	CcSEcCtD
Fexofenadine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000135	0.000777	CcSEcCtD
Fexofenadine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000135	0.000777	CcSEcCtD
Fexofenadine—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000134	0.00077	CcSEcCtD
Fexofenadine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000133	0.000767	CcSEcCtD
Fexofenadine—Dizziness—Metformin—type 2 diabetes mellitus	0.000132	0.000759	CcSEcCtD
Fexofenadine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000131	0.000754	CcSEcCtD
Fexofenadine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00013	0.000751	CcSEcCtD
Fexofenadine—Nausea—Valsartan—type 2 diabetes mellitus	0.00013	0.000749	CcSEcCtD
Fexofenadine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000129	0.000741	CcSEcCtD
Fexofenadine—Nausea—Orlistat—type 2 diabetes mellitus	0.000128	0.00074	CcSEcCtD
Fexofenadine—Asthenia—Losartan—type 2 diabetes mellitus	0.000127	0.000732	CcSEcCtD
Fexofenadine—Vomiting—Metformin—type 2 diabetes mellitus	0.000127	0.00073	CcSEcCtD
Fexofenadine—Rash—Metformin—type 2 diabetes mellitus	0.000126	0.000724	CcSEcCtD
Fexofenadine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000125	0.000723	CcSEcCtD
Fexofenadine—Pruritus—Losartan—type 2 diabetes mellitus	0.000125	0.000721	CcSEcCtD
Fexofenadine—Headache—Metformin—type 2 diabetes mellitus	0.000125	0.000719	CcSEcCtD
Fexofenadine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000124	0.000717	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000124	0.000715	CcSEcCtD
Fexofenadine—Pimozide—CYP3A4—type 2 diabetes mellitus	0.000123	0.0419	CrCbGaD
Fexofenadine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000121	0.000698	CcSEcCtD
Fexofenadine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000121	0.000695	CcSEcCtD
Fexofenadine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.00012	0.000691	CcSEcCtD
Fexofenadine—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.00012	0.000691	CcSEcCtD
Fexofenadine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00012	0.000689	CcSEcCtD
Fexofenadine—Rash—Irbesartan—type 2 diabetes mellitus	0.000119	0.000683	CcSEcCtD
Fexofenadine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000118	0.000683	CcSEcCtD
Fexofenadine—Nausea—Metformin—type 2 diabetes mellitus	0.000118	0.000682	CcSEcCtD
Fexofenadine—Headache—Irbesartan—type 2 diabetes mellitus	0.000118	0.000679	CcSEcCtD
Fexofenadine—Dizziness—Losartan—type 2 diabetes mellitus	0.000117	0.000674	CcSEcCtD
Fexofenadine—Vomiting—Losartan—type 2 diabetes mellitus	0.000112	0.000648	CcSEcCtD
Fexofenadine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000112	0.000644	CcSEcCtD
Fexofenadine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000112	0.000644	CcSEcCtD
Fexofenadine—Rash—Losartan—type 2 diabetes mellitus	0.000112	0.000643	CcSEcCtD
Fexofenadine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000111	0.000642	CcSEcCtD
Fexofenadine—Headache—Losartan—type 2 diabetes mellitus	0.000111	0.000639	CcSEcCtD
Fexofenadine—Methadone—CYP1A2—type 2 diabetes mellitus	0.00011	0.0376	CrCbGaD
Fexofenadine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000109	0.000627	CcSEcCtD
Fexofenadine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000107	0.000619	CcSEcCtD
Fexofenadine—Fentanyl—CYP3A4—type 2 diabetes mellitus	0.000107	0.0363	CrCbGaD
Fexofenadine—Nausea—Losartan—type 2 diabetes mellitus	0.000105	0.000606	CcSEcCtD
Fexofenadine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000104	0.000598	CcSEcCtD
Fexofenadine—Loperamide—CYP3A4—type 2 diabetes mellitus	0.000103	0.035	CrCbGaD
Fexofenadine—Dizziness—Ramipril—type 2 diabetes mellitus	0.0001	0.000578	CcSEcCtD
Fexofenadine—Vomiting—Ramipril—type 2 diabetes mellitus	9.65e-05	0.000556	CcSEcCtD
Fexofenadine—Rash—Ramipril—type 2 diabetes mellitus	9.57e-05	0.000551	CcSEcCtD
Fexofenadine—Dermatitis—Ramipril—type 2 diabetes mellitus	9.56e-05	0.000551	CcSEcCtD
Fexofenadine—Headache—Ramipril—type 2 diabetes mellitus	9.5e-05	0.000548	CcSEcCtD
Fexofenadine—Nausea—Ramipril—type 2 diabetes mellitus	9.01e-05	0.000519	CcSEcCtD
Fexofenadine—Methadone—CYP3A4—type 2 diabetes mellitus	7.31e-05	0.0249	CrCbGaD
Fexofenadine—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	1.25e-05	0.000186	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	1.24e-05	0.000185	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.24e-05	0.000185	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.23e-05	0.000182	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	1.23e-05	0.000182	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	1.23e-05	0.000182	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	1.23e-05	0.000182	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	1.23e-05	0.000182	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.23e-05	0.000182	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	1.23e-05	0.000182	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.2e-05	0.000178	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	1.2e-05	0.000178	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—C3—type 2 diabetes mellitus	1.2e-05	0.000178	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CD36—type 2 diabetes mellitus	1.19e-05	0.000177	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	1.18e-05	0.000175	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GNB3—type 2 diabetes mellitus	1.18e-05	0.000175	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.18e-05	0.000175	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.18e-05	0.000175	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	1.18e-05	0.000175	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—HMOX1—type 2 diabetes mellitus	1.17e-05	0.000174	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.17e-05	0.000173	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PPARG—type 2 diabetes mellitus	1.17e-05	0.000173	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.16e-05	0.000172	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CAT—type 2 diabetes mellitus	1.16e-05	0.000172	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	1.16e-05	0.000171	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—INSR—type 2 diabetes mellitus	1.15e-05	0.000171	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	1.15e-05	0.00017	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—INS—type 2 diabetes mellitus	1.15e-05	0.00017	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	1.14e-05	0.000169	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.13e-05	0.000168	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	1.13e-05	0.000168	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.13e-05	0.000168	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.13e-05	0.000167	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—APOB—type 2 diabetes mellitus	1.13e-05	0.000167	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.12e-05	0.000167	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	1.12e-05	0.000166	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	1.11e-05	0.000165	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.11e-05	0.000165	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	1.11e-05	0.000165	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.11e-05	0.000165	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.11e-05	0.000165	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	1.11e-05	0.000165	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GSTM1—type 2 diabetes mellitus	1.09e-05	0.000162	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—C3—type 2 diabetes mellitus	1.09e-05	0.000161	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	1.08e-05	0.000161	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.08e-05	0.00016	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—AGT—type 2 diabetes mellitus	1.07e-05	0.000159	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—LPL—type 2 diabetes mellitus	1.07e-05	0.000159	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	1.06e-05	0.000158	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.06e-05	0.000157	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—APOE—type 2 diabetes mellitus	1.05e-05	0.000156	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ADCY5—type 2 diabetes mellitus	1.05e-05	0.000156	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.05e-05	0.000156	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—ALB—type 2 diabetes mellitus	1.05e-05	0.000156	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.05e-05	0.000156	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.05e-05	0.000156	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GPX1—type 2 diabetes mellitus	1.05e-05	0.000155	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	1.05e-05	0.000155	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	1.05e-05	0.000155	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	1.05e-05	0.000155	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	1.05e-05	0.000155	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.04e-05	0.000154	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.03e-05	0.000153	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CD36—type 2 diabetes mellitus	1.02e-05	0.000151	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.02e-05	0.000151	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.02e-05	0.000151	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.02e-05	0.000151	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.01e-05	0.00015	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.01e-05	0.00015	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3R1—type 2 diabetes mellitus	1e-05	0.000149	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—NOS3—type 2 diabetes mellitus	1e-05	0.000149	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	1e-05	0.000149	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	9.98e-06	0.000148	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PLAT—type 2 diabetes mellitus	9.94e-06	0.000147	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GHRL—type 2 diabetes mellitus	9.94e-06	0.000147	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	9.89e-06	0.000147	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CALCA—type 2 diabetes mellitus	9.82e-06	0.000146	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—MTHFR—type 2 diabetes mellitus	9.67e-06	0.000143	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	9.55e-06	0.000142	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	9.52e-06	0.000141	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PPARA—type 2 diabetes mellitus	9.49e-06	0.000141	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	9.32e-06	0.000138	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	9.25e-06	0.000137	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	9.23e-06	0.000137	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	9.2e-06	0.000137	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—AGT—type 2 diabetes mellitus	9.19e-06	0.000136	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PTGS2—type 2 diabetes mellitus	9.18e-06	0.000136	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PPARG—type 2 diabetes mellitus	9.17e-06	0.000136	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GCG—type 2 diabetes mellitus	9.09e-06	0.000135	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	9.09e-06	0.000135	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	9.04e-06	0.000134	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	9.04e-06	0.000134	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CALM1—type 2 diabetes mellitus	9.04e-06	0.000134	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—APOE—type 2 diabetes mellitus	9.01e-06	0.000134	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—INS—type 2 diabetes mellitus	9e-06	0.000133	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	8.94e-06	0.000133	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	8.91e-06	0.000132	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—APOA1—type 2 diabetes mellitus	8.9e-06	0.000132	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	8.87e-06	0.000132	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	8.81e-06	0.000131	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	8.81e-06	0.000131	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	8.81e-06	0.000131	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	8.76e-06	0.00013	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	8.7e-06	0.000129	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	8.6e-06	0.000128	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	8.52e-06	0.000126	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	8.52e-06	0.000126	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	8.51e-06	0.000126	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	8.5e-06	0.000126	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	8.36e-06	0.000124	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	8.36e-06	0.000124	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	8.35e-06	0.000124	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	8.35e-06	0.000124	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	8.31e-06	0.000123	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	8.31e-06	0.000123	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	8.31e-06	0.000123	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	8.25e-06	0.000122	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ALB—type 2 diabetes mellitus	8.25e-06	0.000122	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	8.11e-06	0.00012	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	8.01e-06	0.000119	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.91e-06	0.000117	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	7.91e-06	0.000117	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	7.91e-06	0.000117	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	7.91e-06	0.000117	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	7.89e-06	0.000117	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—NOS3—type 2 diabetes mellitus	7.89e-06	0.000117	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PPARG—type 2 diabetes mellitus	7.84e-06	0.000116	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.84e-06	0.000116	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	7.76e-06	0.000115	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AVP—type 2 diabetes mellitus	7.73e-06	0.000115	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.73e-06	0.000115	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.7e-06	0.000114	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—INS—type 2 diabetes mellitus	7.69e-06	0.000114	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	7.69e-06	0.000114	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.66e-06	0.000114	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	7.58e-06	0.000112	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	7.54e-06	0.000112	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	7.53e-06	0.000112	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APOB—type 2 diabetes mellitus	7.47e-06	0.000111	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	7.45e-06	0.000111	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	7.45e-06	0.000111	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	7.45e-06	0.000111	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.44e-06	0.00011	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.35e-06	0.000109	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	7.31e-06	0.000108	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	7.25e-06	0.000107	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	7.23e-06	0.000107	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PTGS2—type 2 diabetes mellitus	7.22e-06	0.000107	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	7.15e-06	0.000106	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	7.15e-06	0.000106	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—LPL—type 2 diabetes mellitus	7.13e-06	0.000106	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	7.09e-06	0.000105	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ALB—type 2 diabetes mellitus	7.05e-06	0.000105	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.98e-06	0.000104	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	6.97e-06	0.000103	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	6.85e-06	0.000102	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	6.85e-06	0.000102	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	6.81e-06	0.000101	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—NOS3—type 2 diabetes mellitus	6.75e-06	0.0001	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	6.75e-06	0.0001	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	6.74e-06	9.99e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	6.74e-06	9.99e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.69e-06	9.93e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.57e-06	9.75e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	6.57e-06	9.75e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	6.46e-06	9.58e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	6.46e-06	9.58e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—C3—type 2 diabetes mellitus	6.42e-06	9.53e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	6.17e-06	9.15e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.13e-06	9.09e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.11e-06	9.06e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AGT—type 2 diabetes mellitus	6.1e-06	9.05e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CALM1—type 2 diabetes mellitus	6e-06	8.9e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APOE—type 2 diabetes mellitus	5.98e-06	8.87e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—LEP—type 2 diabetes mellitus	5.98e-06	8.87e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.91e-06	8.77e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.91e-06	8.76e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	5.91e-06	8.76e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	5.88e-06	8.72e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	5.8e-06	8.61e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.64e-06	8.36e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	5.63e-06	8.36e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.57e-06	8.26e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	5.57e-06	8.26e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	5.54e-06	8.22e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	5.48e-06	8.13e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	5.47e-06	8.11e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	5.38e-06	7.98e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.33e-06	7.91e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	5.31e-06	7.87e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	5.27e-06	7.81e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	5.25e-06	7.78e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	5.16e-06	7.66e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	5.11e-06	7.58e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	5.11e-06	7.58e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	5.07e-06	7.52e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	5.05e-06	7.49e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.03e-06	7.46e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	4.96e-06	7.36e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	4.94e-06	7.33e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.94e-06	7.33e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.94e-06	7.32e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.92e-06	7.29e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	4.84e-06	7.18e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	4.82e-06	7.14e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	4.76e-06	7.05e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	4.75e-06	7.05e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.69e-06	6.96e-05	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—AKT1—type 2 diabetes mellitus	4.62e-06	6.85e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	4.6e-06	6.83e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	4.56e-06	6.77e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	4.52e-06	6.71e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	4.51e-06	6.69e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.48e-06	6.64e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.48e-06	6.64e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	4.48e-06	6.64e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	4.46e-06	6.61e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	4.34e-06	6.43e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	4.26e-06	6.32e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	4.25e-06	6.3e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.22e-06	6.25e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	4.2e-06	6.23e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	3.93e-06	5.82e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	3.85e-06	5.71e-05	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.84e-06	5.69e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.8e-06	5.64e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.78e-06	5.6e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	3.7e-06	5.49e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	3.63e-06	5.38e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—AKT1—type 2 diabetes mellitus	3.63e-06	5.38e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.59e-06	5.33e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.56e-06	5.27e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	3.53e-06	5.24e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.49e-06	5.17e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.38e-06	5.01e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	3.38e-06	5.01e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	3.33e-06	4.94e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.31e-06	4.92e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.23e-06	4.79e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.18e-06	4.72e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	3.18e-06	4.72e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	3.1e-06	4.6e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	3.09e-06	4.58e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.96e-06	4.39e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.91e-06	4.32e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.9e-06	4.31e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.23e-06	3.31e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.06e-06	3.05e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.55e-06	2.3e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.46e-06	2.17e-05	CbGpPWpGaD
